IVDs and data requirements in a value-based reimbursement landscape
The value of data to the in vitro diagnostics industry has never been more apparent. At every corner of the healthcare industry, data is being used to help doctors make the best treatment decisions for their patients, to help hospital executives prioritize value-based initiatives, and to find new indications for existing medications. Because in vitro diagnostics are so integral to patient care, particularly for oncology, developers must be aware of how quality and efficacy data pertaining to their device will be used.
The rest of this my piece is published here: http://medcitynews.com/2017/09/ivds-data-requirements-value-based-reimbursement-landscape/
Sorry for the redirection, but since it is being published I want to make sure I point everyone in the right direction. If you do like the piece, please let me know here and I can write more on this topic or similar topics.